We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.71B
1-Year Est. Return 81.93%
This Fund
S&P 500
This Quarter Est. Return
+4.3%
1 Year Est. Return
+81.93%
3 Year Est. Return
+319.13%
5 Year Est. Return
+526.52%
10 Year Est. Return
+4,797.43%
AUM
$3.86B
AUM Growth
-$1.59B
Cap. Flow
-$1.68B
Cap. Flow %
-43.43%
Top 10 Hldgs %
19.14%
Holding
821
New
112
Increased
267
Reduced
93
Closed
295
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLLI
226
DELISTED
Globalink Investment Inc. Common Stock
GLLI
$2.1M 0.05%
205,998
+49,444
+32% +$497K
UHG
227
DELISTED
United Homes Group
UHG
$2.06M 0.05%
205,152
+7,252
+4% +$72.2K
ATMVU
228
DELISTED
AlphaVest Acquisition Corp Unit
ATMVU
$2.02M 0.05%
+200,033
New +$2.02M
FSNB
229
DELISTED
Fusion Acquisition Corp. II
FSNB
$2M 0.05%
198,773
-242,077
-55% -$2.41M
ALSA
230
DELISTED
Alpha Star Acquisition Corp
ALSA
$1.97M 0.05%
192,311
+46,690
+32% +$475K
AILE
231
DELISTED
iLearningEngines, Inc. Common Stock
AILE
$1.94M 0.05%
193,591
+16,867
+10% +$168K
FZT
232
DELISTED
FAST Acquisition Corp. II
FZT
$1.93M 0.05%
192,263
+170,812
+796% +$1.69M
PTOC
233
DELISTED
Pine Technology Acquisition Corp. Class A Common Stock
PTOC
$1.91M 0.05%
190,280
-50,121
-21% -$498K
ADOC
234
DELISTED
Edoc Acquisition Corp. Class A Ordinary Share
ADOC
$1.86M 0.05%
+177,533
New +$1.85M
IVCP
235
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
$1.86M 0.05%
183,893
+170,712
+1,295% +$1.72M
BSLK
236
DELISTED
Bolt Projects Holdings
BSLK
$1.84M 0.05%
9,212
+7,055
+327% +$1.41M
TGR
237
DELISTED
Kimbell Tiger Acquisition Corporation
TGR
$1.8M 0.05%
175,100
-216,574
-55% -$2.21M
PFTA
238
DELISTED
Perception Capital Corp. III Class A Ordinary Share
PFTA
$1.75M 0.05%
174,004
-38,800
-18% -$386K
BIOS
239
DELISTED
BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS
$1.72M 0.04%
167,915
+14,448
+9% +$147K
ACAH
240
DELISTED
Atlantic Coastal Acquisition Corp. Class A Common Stock
ACAH
$1.7M 0.04%
169,665
+47,236
+39% +$469K
STET
241
DELISTED
ST Energy Transition I Ltd.
STET
$1.69M 0.04%
165,741
+28,319
+21% +$286K
TPBA
242
DELISTED
TPB Acquisition Corporation I Class A Ordinary Share
TPBA
$1.69M 0.04%
168,755
+158,586
+1,560% +$1.57M
XFIN
243
DELISTED
ExcelFin Acquisition Corp Class A Common Stock
XFIN
$1.67M 0.04%
+163,953
New +$1.66M
FTPA
244
DELISTED
FTAC Parnassus Acquisition Corp. Class A Common Stock
FTPA
$1.67M 0.04%
165,980
-189,701
-53% -$1.89M
APEN
245
DELISTED
Apollo Endosurgery, Inc.
APEN
$1.63M 0.04%
+162,947
New +$1.22M
AAGR
246
DELISTED
African Agriculture Holdings Inc
AAGR
$1.61M 0.04%
226,660
-2,201,155
-91% -$15.7M
ACBA
247
DELISTED
Ace Global Business Acquisition Ltd
ACBA
$1.61M 0.04%
151,358
+75,145
+99% +$794K
OTEC
248
DELISTED
OceanTech Acquisitions I Corp. Class A Common Stock
OTEC
$1.58M 0.04%
150,000
+118,134
+371% +$1.22M
APCA
249
DELISTED
AP Acquisition Corp
APCA
$1.56M 0.04%
151,243
+12,766
+9% +$131K
CDT icon
250
CDT Equity Inc
CDT
$1.85M
0

Similar funds

Glazer Capital LLC's Q4 2022 Portfolio in Review

As of Q4 2022, Glazer Capital LLC held 821 positions worth $3.86B, down 29% from $5.46B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glazer Capital LLC withdrew a net $1.68B in Q4 2022, closing 295 positions and reducing 93 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $187M position sold in full.

By sector, the portfolio is most concentrated in Financials at 69% of assets, up from 64% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glazer Capital LLC opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $41M.

  • Glazer Capital LLC's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 360,496 shares worth $41M.
  • Glazer Capital LLC added most to Jaws Mustang Acquisition Corp. in Q4 2022, an estimated $52.5M increase.
  • Glazer Capital LLC's biggest Q4 2022 reduction was Envoy Medical, cutting an estimated $34M.
  • Glazer Capital LLC fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $187M.
  • Glazer Capital LLC's ten largest holdings make up 19% of its $3.86B portfolio in Q4 2022.
  • Glazer Capital LLC opened 112 new positions and closed 295 in Q4 2022.
  • Glazer Capital LLC's portfolio value fell 29% quarter-over-quarter to $3.86B.

Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.